首页> 外文期刊>Biomolecular Detection and Quantification >The potential of circulating extracellular small {RNAs} (smexRNA) in veterinary diagnostics—Identifying biomarker signatures by multivariate data analysis
【24h】

The potential of circulating extracellular small {RNAs} (smexRNA) in veterinary diagnostics—Identifying biomarker signatures by multivariate data analysis

机译:循环细胞外小{RNAs}(smexRNA)在兽医诊断中的潜力-通过多变量数据分析识别生物标志物特征

获取原文
           

摘要

Abstract Worldwide growth and performance-enhancing substances are used in cattle husbandry to increase productivity. In certain countries however e.g., in the EU, these practices are forbidden to prevent the consumers from potential health risks of substance residues in food. To maximize economic profit, ‘black sheep‘ among farmers might circumvent the detection methods used in routine controls, which highlights the need for an innovative and reliable detection method. Transcriptomics is a promising new approach in the discovery of veterinary medicine biomarkers and also a missing puzzle piece, as up to date, metabolomics and proteomics are paramount. Due to increased stability and easy sampling, circulating extracellular small {RNAs} (smexRNAs) in bovine plasma were small RNA-sequenced and their potential to serve as biomarker candidates was evaluated using multivariate data analysis tools. After running the data evaluation pipeline, the proportion of miRNAs (microRNAs) and piRNAs (PIWI-interacting small non-coding RNAs) on the total sequenced reads was calculated. Additionally, top 10 signatures were compared which revealed that the readcount data sets were highly affected by the most abundant miRNA and piRNA profiles. To evaluate the discriminative power of multivariate data analyses to identify animals after veterinary drug application on the basis of smexRNAs, OPLS-DA was performed. In summary, the quality of miRNA models using all mapped reads for both treatment groups (animals treated with steroid hormones or the β-agonist clenbuterol) is predominant to those generated with combined data sets or piRNAs alone. Using multivariate projection methodologies like OPLS-DA have proven the best potential to generate discriminative miRNA models, supported by small RNA-Seq data. Based on the presented comparative OPLS-DA, miRNAs are the favorable smexRNA biomarker candidates in the research field of veterinary drug abuse.
机译:摘要畜牧业使用世界范围内的增长和提高性能的物质来提高生产率。但是在某些国家,例如在欧盟,禁止这些做法以防止消费者遭受食品中残留物质的潜在健康危害。为了最大化经济利益,农民中的“败类”可能会规避常规控制中使用的检测方法,这凸显了对创新和可靠检测方法的需求。转录组学是发现兽药生物标志物的一种有前途的新方法,也是一个缺失的难题,因为迄今为止,代谢组学和蛋白质组学至关重要。由于增加的稳定性和易于采样的作用,牛血浆中循环的细胞外小{RNA}(smexRNA)进行了小RNA测序,并使用多元数据分析工具评估了其作为生物标志物候选物的潜力。运行数据评估流程后,计算了总测序读段中miRNA(microRNA)和piRNA(与PIWI相互作用的小非编码RNA)的比例。此外,比较了前10个签名,这表明读取计数数据集受到最丰富的miRNA和piRNA谱图的高度影响。为了评估在基于smexRNA的兽药应用后对动物进行识别的多变量数据分析的判别力,执行了OPLS-DA。总之,两个治疗组(使用类固醇激素或β-激动剂克仑特罗处理的动物)使用所有映射读数的miRNA模型的质量主要取决于单独使用组合数据集或piRNA生成的模型。已经证明,使用OPLS-DA等多元投影方法可以产生具有判别力的miRNA模型,并有少量RNA-Seq数据支持。基于提出的比较性OPLS-DA,miRNA是兽药滥用研究领域中有利的smexRNA生物标志物候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号